As deficits in type-1–IFN signaling have been associated with severe COVID-19 in both nonpregnant individuals (46) and mice (47), our data suggest that maternal morbidity may, in part, be due to an inability of pregnant dams to control viral replication because of a reduced type-1–IFN responses, particularly during late gestation. Here, IFNA1 is linked to COVID-19.